Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 Inhibitors

Background  The development of immune-related adverse effects (irAEs) can corroborate with the response to immune checkpoint inhibitors (ICIs), including programmed cell death 1 (PD1) inhibitors. However, there is extremely limited data on the association of irAEs with survival in patients who have...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Akhil, Noronha, Vanita, Patil, Vijay M., Joshi, Amit, Menon, Nandini, Kumar, Amit, Mahajan, Abhishek, Janu, Amit, Kumar, Rajiv, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902094/
https://www.ncbi.nlm.nih.gov/pubmed/36756103
http://dx.doi.org/10.1055/s-0041-1740243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902094/
https://www.ncbi.nlm.nih.gov/pubmed/36756103
http://dx.doi.org/10.1055/s-0041-1740243

Ejemplares similares